Ryan Crowe | Vice President, Investor Relations |
Leonard Schleifer | Co-Founder, President and Chief Executive Officer |
George Yancopoulos | Co-Founder, President and Chief Scientific Officer |
Marion McCourt | Executive Vice President and Head, Commercial |
Bob Landry | Executive Vice President and Chief Financial Officer |
Tyler Van Buren | Cowen |
Matthew Harrison | Morgan Stanley |
Carter Gould | Barclays |
Brian Abrams | RBC Capital Markets |
Evan Seigerman | BMO Capital Markets |
Salveen Richter | Goldman Sachs |
Mohit Bansal | Wells Fargo |
Colin Bristow | UBS |
Chris Raymond | Piper Sandler |
Chris Schott | JPMorgan |
Robyn Karnauskas | Truist |
Welcome to the Regeneron Pharmaceuticals’ Fourth Quarter 2022 Earnings Conference Call. My name is Shannon and I will be your operator for today’s call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Please note that this conference is being recorded.